Prestige Brands: Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024

Prestige Consumer Healthcare Inc. reported earnings results for the third quarter and nine months ended December 31, 2024. For the third quarter, the company reported sales was USD 290 million compared to USD 282.72 million a year ago. Revenue was USD 290.32 million compared to USD 282.74 million a year ago. Net income was USD 61.03 million compared to USD 53.05 million a year ago. Basic earnings per share from continuing operations was USD 1.23 compared to USD 1.07 a year ago. Diluted earnings per share from continuing operations was USD 1.22 compared to USD 1.06 a year ago. For the nine months, sales was USD 841.24 million compared to USD 848.37 million a year ago. Sales was USD 840.39 million compared to USD 848.32 million a year ago. Revenue was USD 841.24 million compared to USD 848.37 million a year ago. Net income was USD 164.48 million compared to USD 159.88 million a year ago. Net income was USD 164.48 million compared to USD 159.88 million a year ago. Basic earnings per share from continuing operations was USD 3.31 compared to USD 3.21 a year ago. Basic earnings per share from continuing operations was USD 3.31 compared to USD 3.21 a year ago. Diluted earnings per share from continuing operations was USD 3.28 compared to USD 3.19 a year ago. Diluted earnings per share from continuing operations was USD 3.28 compared to USD 3.19 a year ago.